Anti-Human Casp-4 (NT)

Anti-Human Casp-4 (NT)

Product No.: C1222

[product_table name="All Top" skus="C1222"]

- -
- -
Target
Casp-4
Product Type
Polyclonal Antibody
Alternate Names
Caspase-4, ICH-2, ICE relII, Mih1
Applications
IHC FFPE
,
WB

- -
- -
Select Product Size

Data

- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Immunogen
PN:C1270
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Rabbit Anti-Human Casp-4 recognizes an epitope near the N-terminus of mouse and human Casp-4. This polyclonal antibody was purified using affinity chromatography.
Background
Caspases are a family of cysteine proteases that can be divided into the apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens.1 Members of this subfamily include caspase-1, -4, -5, and -12. Activation of these caspases results in the cleavage and activation of proinflammatory cytokines such as IL-1β and IL-18.2,3 Caspase-4 was initially identified as a homologous protein to Caspase-1 and the C. elegans Ced-3 which could induce apoptosis in transfected cells.4 More recent studies have shown that it can be activated by ER stress and has been suggested to be involved in multiple neuronal pathologies such as Alzheimer’s disease.5
PubMed

References & Citations

1. Martinon, F. and Tschopp, J. (2004) Cell 117:561-74.
2. Flavell, RA. et al. Science 267:2000-3.
3. Gracie, JA. et al. (2003) J. Leukoc. Biol. 73:213-224.
4. Ghayur, T. et al. (1995) J. Biol. Chem. 270:15250-6.
IHC FFPE
General Western Blot Protocol

Certificate of Analysis

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.